Hepatitis B (HBsAg) prevalence among obstetric patients in Caluquembe, Angola, 2023-2024

Anna E Eberwein1, Priscila Ribeiro Cummings1, Daniel Cummings1

  • 1Hospital Evangélico de Caluquembe, Caluquembe, Huíla, Angola.

Plos One
|July 3, 2025
PubMed

Insights

Hepatitis B virus (HBV) infection prevalence was 4.7% among pregnant women in rural Angola. Most were unaware of their status, highlighting the need for HBV screening during antenatal care to protect newborns.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Hepatitis B virus (HBV) infection at birth leads to chronic disease, cirrhosis, liver cancer, and death.
  • Birth dose hepatitis B vaccine is crucial for preventing vertical transmission and lifelong illness.
  • Limited data exists on HBV prevalence among pregnant populations in rural Angola.

Purpose of the Study:

  • To determine the prevalence of hepatitis B surface antigen (HBsAg) among maternity patients in Huíla province, Angola.
  • To assess knowledge of hepatitis B and vaccination among pregnant women.
  • To identify barriers and facilitators for HBV prevention in a rural Angolan setting.

Main Methods:

  • Prospective case series study of 317 peripartum women at Hospital Evangélico de Caluquembe (November 2023 - February 2024).
  • Point-of-care HBsAg testing for all participants.
  • Qualitative interviews with 26 healthcare workers regarding HBV prevention strategies.

Main Results:

  • HBsAg prevalence was 4.7% among the studied population.
  • None of the HBsAg-positive women were aware of their infection status prior to the study.
  • Low awareness of hepatitis B and vaccination (one-third familiarity); minimal HBV vaccine uptake in older children.
  • Healthcare workers suggested community meetings for education on HBV and birth-dose vaccination.

Conclusions:

  • Antenatal care visits present a critical opportunity for hepatitis B screening, as over 80% of women attend at least one visit.
  • Integrating HBsAg screening into routine antenatal care is essential for timely intervention and preventing mother-to-child transmission of HBV.
  • Improved access to and uptake of hepatitis B screening are vital to ensure newborns receive timely birth-dose vaccination.
Abstract

Related Concept Videos

Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
3.4K
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
93
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
81
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
25